# Citius Pharmaceuticals, Inc. (CTXR)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CTXR/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 7.11M | $ -38.31M | $ -22.99M | $ 7.18M | $ 66.61M |
| 2025 | $ 0 | $ -38.33M | $ -27.19M | $ 1.81M | $ 67.55M |
| 2024 | $ 0 | $ -41.14M | $ -29.64M | $ 262.9K | $ 70.08M |
| 2023 | $ 0 | $ -35.19M | $ -31.42M | $ 481.2K | $ 90.83M |
| 2022 | $ 0 | $ -37.58M | $ -31.68M | $ 678.2K | $ 102.83M |
| 2021 | $ 0 | $ -27.40M | $ -76.38M | $ 855.5K | $ 132.18M |
| 2020 | $ 0 | $ -22.36M | $ -21.57M | $ 1.35M | $ 33.67M |
| 2019 | $ 0 | $ -20.09M | $ -16.05M | $ 173.0K | $ 24.38M |
| 2018 | $ 0 | $ -16.56M | $ -14.95M | $ 173.0K | $ 27.87M |
| 2017 | $ 0 | $ -13.99M | $ -10.74M | $ 173.0K | $ 21.95M |
| 2016 | $ 0 | $ -11.41M | $ -8.12M | $ 673.0K | $ 16.77M |
| 2015 | $ 0 | $ -4.07M | $ -3.35M | $ 0 | $ -635.2K |
| 2014 | $ 0 | $ -889.1K | $ -181.2K | $ 600.0K | $ -741.9K |
| 2013 | $ 0 | $ -44.6K | $ -29.3K | $ 3.2K | $ -14.7K |
| 2012 | $ 0 | $ -31.8K | $ -29.3K | $ 17.0K | $ -45.8K |
| 2011 | $ 0 | $ -38.7K | $ -30.5K | $ 18.5K | $ -23.8K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.11 |
| Liabilities / Eq | 1.00 |
| Current Ratio | 0.84 |

## Other views

- [Metrics](https://sponda.capital/en/CTXR.md)
- [Charts](https://sponda.capital/en/CTXR/charts.md)
- [Compare](https://sponda.capital/en/CTXR/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.